Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17β-oestradiol in MCF7 human breast cancer cells

Journal of Applied Toxicology

Volumn 27, Issue 1, 2007, Pages 67-77

  Pugazhendhi, D ^a   Sadler, A J ^a   Darbre, P D ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Breast cancer cells; Environmental oestrogen; Global gene expression profiles; MCF7 cells; Microarray; Parabens

Indexed keywords

BUTYL PARABEN; ESTRADIOL; METHYL PARABEN; PROGESTERONE RECEPTOR; PROTEIN PS2;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; UNINDEXED SEQUENCE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; FOOD PRESERVATIVES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARABENS; PRESERVATIVES, PHARMACEUTICAL; RNA, MESSENGER; UP-REGULATION;

EID: 33846572404     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1200     Document Type: Article

References (54)

1. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM. 2000. The estrogen receptor binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 54: 138-153.
2. Byford JR, Shaw LE, Drew MGB, Pope GS, Sauer MJ, Darbre PD. 2002. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 80: 49-60.
3. Cicatiello L, Scafoglio C, Altucci L, Canemi M, Natoli G, Facchiano A, Iazzetti G, Calogero R, Biglia N, DeBortoli M, Sfiligoi C, Sismondi P, Bresciani F, Weisz A. 2004. A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. J. Mol. Endocrinol. 32: 719-775.
4. Cunliffe HE, Ringner M, Bilke S, Walker RL, Cheung JM, Chen Y, Meltzer PS. 2003. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res. 63: 7158-7166.
5. Daly RJ, Darbre PD. 1990. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells. Cancer Res. 50: 5868-5875.
6. Darbre PD. 2006. Environmental oestrogens, cosmetics and breast cancer. Best Pract. Clin. Endocrinol. Metab. 20: 121-143.
7. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. 2004. Concentrations of parabens in human breast tumours. J. Appl. Toxicol. 24: 5-13.
8. Darbre PD, Byford JR, Shaw LE, Hall S, Coldham NG, Pope GS, Sauer MJ. 2003. Oestrogenic activity of benzylparaben. J. Appl. Toxicol. 23: 43-51.
9. Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS, Sauer MJ. 2002. Oestrogenic activity of isobutylparaben in vitro and in vivo. J. Appl. Toxicol. 22: 219-226.
10. Darbre PD, Daly RJ. 1989. Effects of oestrogen on human breast cancer cells in culture. Proc. R. Soc. Edinb. 95B: 119-132.
11. Darbre P, Yates J, Curtis SA, King RJB. 1983. Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43: 349-354.
12. Elder RL. 1984. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben. J. Am. Coll. Toxicol. 3: 147-209.
13. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM. 2001. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol. 14: 280-294.
14. Frasor J, Danes JM, Komm B, Chang KCN, Lyttle CR, Katzenellenbogen BS. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574.
15. Glover JF, Irwin JT, Darbre PD. 1988. Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D. Cancer Res. 48: 3693-3697.
16. Harvey PW, Darbre P. 2004. Endocrine disrupters and human health: Could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? A review of evidence and call for further research. J. Appl. Toxicol. 24: 167-176.
17. Harvey PW, Everett DJ. 2006. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health. Best Pract. Res. Clin. Endocrinol. Metab. 20: 145-165.
18. Hess JL. 2004. Mechanisms of transformation by MLL. Crit. Rev. Eukaryot. Gene Expr. 14: 235-254.
19. Hihi AK, Wahli W. 1999. Structure and function of the estrogen receptor. In Estrogens and Antiestrogens I, Oettel M, Schillinger E (eds). Springer-Verlag: Berlin; 111-126.
20. Hossaini A, Larsen JJ, Larsen JC. 2000. Lack of oestrogenic effects of food preservatives (parabens) in uterotropic assays. Food Chem. Toxicol. 38: 319-323.
21. Jin-Sung P, Lee BJ, Kang KS, Tai JH, Cho JJ, Cho MH, Inoue T, Lee YS. 2000. Hormonal effects of several chemicals in recombinant yeast, MCF7 cells and uterotropic assays in mice. Microbiol. Biotechnol. 10: 293-299.
22. Key TJ, Verkasalo PK, Banks E. 2001. Epidemiology of breast cancer. Lancet Oncol. 2: 133-140.
23. Kroll T, Odyvanova L, Clement JH, Platzer C, Naumann A, Marr N, Hoffken K, Wolfl S. 2002. Molecular characterization of breast cancer cell lines by expression profiling. J. Cancer Res. Clin. Oncol. 128. 125-134.
24. Lee HB, Peart TE, Svoboda ML. 2005. Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry. J. Chromatogr. 1094: 122-129.
25. Lemini C, Jaimez R, Avila ME, Franco Y, Larrea F, Lemus AE. 2003. In vivo and in vitro estrogen bioactivities of alkyl parabens. Toxicol. Ind. Health 19: 69-79.
26. Lemini C, Silva G, Timossi C, Luque D, Valverde A, Gonzalez-Martinez M, Hernandez A, Rubio-Poo C, Chavez Lara B, Valenzuela F. 1997. Estrogenic effects of p-hydroxybenzoic acid in CD1 mice. Environ. Res. 75: 130-134.
27. Lipworth L. 1995. Epidemiology of breast cancer. Eur. J. Cancer Prevent. 4: 7-30.
28. Lonning PE (ed.). 2004. Endocrinology and treatment of breast cancer. Best Pract. Res. Clin. Endocrinol. Metab. 18: 1-130.
29. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. 1982. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10: 7895-7903.
30. Miller WR. 1996. Estrogen and Breast Cancer. Chapman and Hall: London.
31. Mo R, Rao SM, Zhu YJ. 2006. Identification of the MLL2 complex as a coactivator for estrogen receptor alpha. J. Biol. Chem. 281: 15714-15720.
32. Newby JA, Howard CV. 2005. Environmental influences in cancer aetiology. J. Nutr. Environ. Med. 15: 56-114.
33. Nikitenko LL, Fox SB, Kehoe S, Rees MCP, Bicknell R. 2006. Adrenomedullin and tumour angiogenesis. Br. J. Cancer 94: 1-7.
34. Nishihara T, Nishikawa JI, Kanayama T, Dakeyama F, Saito K, Imagawa M, Takatori S, Kitagawa Y, Hori S, Utsumi H. 2000. Estrogenic activities of 517 chemicals by yeast two-hybrid assay. J Health Sci. 46: 282-298.
35. Okubo T, Yokoyama Y, Kano K, Kano I. 2001. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERα and PR. Food Chem. Toxicol. 39: 1225-1232.
36. Osborne CK, Hobbs K, Trent JM. 1987. Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res. Treat. 9: 111-121.
37. Pedersen KL, Pedersen SN, Christiansen LB, Korsgaard B, Bjerregaard P. 2000. The preservatives ethyl-, propyl-, and butylparaben are oestrogenic in an in vivo fish assay. Pharmacol. Toxicol. 86: 110-113.
38. Prasad R, Zhadanov AB, Sedkov Y, Bullrich F, Druck T, Rallapalli R, Yano T, Alder H, Croce CM, Huebner K, Mazo A, Canaani E. 1997. Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax. Oncogene 15: 549-560.
39. Pugazhendhi D, Pope GS, Darbre PD. 2005. Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines. J. Appl. Toxicol. 25: 301-309.
40. Rastogi SC, Schouten A, De Kruijf N, Weijland JW. 1995. Contents of methyl-, ethyl-, propyl-, butyl- and benzylparaben in cosmetic products. Contact Dermat. 32: 28-30.
41. Rocques PJ, Clark J, Ball S, Crew J, Gill S, Christadoulou Z, Borts RH, Louis EJ, Davies KE, Cooper CS. 1995. The human SB1.8 gene (DXS423E) encodes a putative chromosome segregation protein conserved in lower eukaryotes and prokaryotes. Hum. Mol. Genet. 4: 243-249.
42. Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP. 1998. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol. Appl. Pharmacol. 153: 12-19.
43. Sadler AJ. 2006. Identification of Novel Genes Associated with Endocrine Resistance in Breast Cancer. PhD thesis, University of Reading, UK.
44. Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Lebedeva IV, Dent P, Pestka S, Fisher PB. 2003. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14: 35-51.
45. Schmiesing JA, Ball AR, Gregson HC, Alderton JM, Zhou S, Yokomori K. 1998. Identification of two distinct human SMC protein complexes involved in mitotic chromosome dynamics. Proc. Natl Acad. Sci. USA 95: 12906-12911.
46. Shaw LE, Sadler AJ, Pugazhendhi D, Darbre PD. 2006. Changes in oestrogen receptor-α and -β during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 99: 19-32.
47. Soni MG, Carabin IG, Burdock GA. 2005. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem. Toxicol. 43: 985-1015.
48. Stephen R, Darbre PD. 2000. Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid. Br. J. Cancer 83: 1183-1191.
49. Stephen R, Shaw LE, Larsen C, Corcoran D, Darbre PD. 2001. Insulin-like growth factor receptor levels are regulated by cell density and by long-term estrogen deprivation in MCF7 human breast cancer cells. J. Biol. Chem. 276: 40080-40086.
50. Terasaka S, Aita Y, Inoue A, Hayashi S, Nishigaki M, Aoyagi K, Sasaki H, Wada-Kiyama Y, Sakuma Y, Akaba S, Tanaka J, Sone H, Yonemoto J, Tanji M, Kiyama R. 2004. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial estrogens. Environ. Health Perspect. 112: 773-781.
51. Terasaka S, Inoue A, Tanji M, Kiyama R. 2006. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol. Lett. 163: 130-141.
52. Waring RH, Harris M. 2005. Endocrine disrupters: a human risk? Mol. Cell. Endocrinol. 244: 2-9.
53. Yazdi PT, Wang Y, Zhao S, Patel N, Lee EYHP, Qin J. 2002. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16: 571-582.
54. Ye X, Kuklenyik Z, Bishop AM, Needham LL, Calafat AM. 2006. Quantification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J. Chromatogr. [EPub ahead of print].